Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?
Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?, Published online: 04 February 2019; doi:10.1038/s41397-019-0078-0Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 4, 2019 Category: Drugs & Pharmacology Authors: Federico Nichetti Felicia Stefania Falvella Rosalba Miceli Stefania Cheli Raffaella Gaetano Giovanni Fuc à Gabriele Infante Antonia Martinetti Carlotta Antoniotti Alfredo Falcone Maria Di Bartolomeo Chiara Cremolini Filippo de Braud Filippo Pietrantonio Source Type: research
Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP
Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP, Published online: 31 January 2019; doi:10.1038/s41397-019-0067-3Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 31, 2019 Category: Drugs & Pharmacology Authors: Eleanor M. Wigmore Jonathan D. Hafferty Lynsey S. Hall David M. Howard Toni-Kim Clarke Chiara Fabbri Cathryn M. Lewis Rudolf Uher Lauren B. Navrady Mark J. Adams Yanni Zeng Archie Campbell Jude Gibson Pippa A. Thomson Caroline Hayward Blair H. Smith Lynne Source Type: research
Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib
Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib, Published online: 28 January 2019; doi:10.1038/s41397-019-0075-3Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 28, 2019 Category: Drugs & Pharmacology Authors: Marta Schirripa Beatrice Borelli Romina D ’Aurizio Simone Lubrano Chiara Cremolini Gemma Zucchelli Carlotta Antoniotti Federica Marmorino Alessandra Anna Prete Sabina Murgioni Francesca Bergamo Vittorina Zagonel Andrea Tuccoli Andrea Marranci Milena Riz Source Type: research
Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab
Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab, Published online: 18 January 2019; doi:10.1038/s41397-019-0073-5Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 18, 2019 Category: Drugs & Pharmacology Authors: T. Magnes T. Melchardt C. Hufnagl L. Weiss C. Mittermair D. Neureiter E. Klieser G. Rinnerthaler S. Roesch A. Gaggl R. Greil A. Egle Source Type: research
Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure
Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure, Published online: 17 January 2019; doi:10.1038/s41397-019-0068-2Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 17, 2019 Category: Drugs & Pharmacology Authors: Peter R. Hansen Karl Emil Nelveg-Kristensen Henrik B. Rasmussen Christian Torp-Pedersen Lars K øber Claus Henrik Nielsen Christian Enevold Source Type: research
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients, Published online: 17 January 2019; doi:10.1038/s41397-019-0071-7The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 17, 2019 Category: Drugs & Pharmacology Authors: Sarah Allegra Jessica Cusato Silvia De Francia Filomena Longo Elisa Pirro Davide Massano Valeria Avataneo Amedeo De Nicol ò Antonio Piga Antonio D ’Avolio Source Type: research
A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients
A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients, Published online: 16 January 2019; doi:10.1038/s41397-019-0072-6A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 16, 2019 Category: Drugs & Pharmacology Authors: C écile Luxembourger Adeline Ruyssen-Witrand Chayma Ladhari C écile Rittore Yannick Degboe Jean-Francis Maillefert Philippe Gaudin Hubert Marotte Daniel Wendling Christian Jorgensen Alain Cantagrel Arnaud Constantin Delphine Nigon Isabelle Touitou Jacqu Source Type: research
Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention
Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention, Published online: 16 January 2019; doi:10.1038/s41397-019-0069-1Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 16, 2019 Category: Drugs & Pharmacology Authors: Vasilios Fragoulakis Marina Bartsakoulia Xando D íaz-Villamarín Konstantina Chalikiopoulou Konstantina Kehagia Jes ús Gabriel Sánchez Ramos Luis Javier Mart ínez-González Maria Gkotsi Eva Katrali Efthimios Skoufas Athanassios Vozikis Anne John Bassa Source Type: research
Warfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients – a randomized, prospective study
Warfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients – a randomized, prospective study, Published online: 16 January 2019; doi:10.1038/s41397-019-0066-4Warfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients – a randomized, prospective study (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 16, 2019 Category: Drugs & Pharmacology Authors: Tereza Ruzickova Martin Sramek Vojtech Kaplan Simona Kumstyrova Zuzana Lacinova Petr Jansky Hana Magerova Ivana Sarbochova Jaroslava Paulasova Schwabova Vaclav Matoska Ales Tomek Source Type: research
An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care
An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care, Published online: 16 January 2019; doi:10.1038/s41397-019-0070-8An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 16, 2019 Category: Drugs & Pharmacology Authors: Reinier L. Sluiter Joost G. E. Janzing Gert Jan van der Wilt Wietske Kievit Martina Teichert Source Type: research
Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing
Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing, Published online: 16 November 2018; doi:10.1038/s41397-018-0063-zIdentification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - November 16, 2018 Category: Drugs & Pharmacology Authors: Casey R. Dorr Baolin Wu Rory P. Remmel Amutha Muthusamy David P. Schladt Juan E. Abrahante Weihua Guan Roslyn B. Mannon Arthur J. Matas William S. Oetting Pamala A. Jacobson Ajay K. Israni Arthur J. Matas J. Michael Cecka John E. Connett Fernando G. Cosio Source Type: research
Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?
Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?, Published online: 08 November 2018; doi:10.1038/s41397-018-0064-yTenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization? (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - November 8, 2018 Category: Drugs & Pharmacology Authors: A. Calcagno M. Fiuman ò D. Zugna J. Cusato C. Montrucchio L. Marinaro L. Trentini M. Ferrara A. D ’Avolio C. Pizzi G. Di Perri S. Bonora Source Type: research
Iatrogenic hypertension: a bioinformatic analysis
Iatrogenic hypertension: a bioinformatic analysis, Published online: 05 November 2018; doi:10.1038/s41397-018-0062-0Iatrogenic hypertension: a bioinformatic analysis (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - November 5, 2018 Category: Drugs & Pharmacology Authors: Alon Botzer Yoram Finkelstein Ehud Grossman John Moult Ron Unger Source Type: research
Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African–Americans with opioid use disorder
Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African–Americans with opioid use disorder, Published online: 27 October 2018; doi:10.1038/s41397-018-0065-xReplication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African–Americans with opioid use disorder (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 27, 2018 Category: Drugs & Pharmacology Authors: Richard C. Crist Karran A. Phillips Melody A. Furnari Landhing M. Moran Glenn A. Doyle Laura F. McNicholas James W. Cornish Kyle M. Kampman Kenzie L. Preston Wade H. Berrettini Source Type: research
Impact of single nucleotide polymorphisms on P450 oxidoreductase and peroxisome proliferator-activated receptor alpha on tacrolimus pharmacokinetics in renal transplant recipients
Impact of single nucleotide polymorphisms on P450 oxidoreductase and peroxisome proliferator-activated receptor alpha on tacrolimus pharmacokinetics in renal transplant recipients, Published online: 15 October 2018; doi:10.1038/s41397-018-0061-1Impact of single nucleotide polymorphisms on P450 oxidoreductase and peroxisome proliferator-activated receptor alpha on tacrolimus pharmacokinetics in renal transplant recipients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 15, 2018 Category: Drugs & Pharmacology Authors: Shuhui Si Zijie Wang Haiwei Yang Zhijian Han Jun Tao Hao Chen Ke Wang Miao Guo Ruoyun Tan Ji-Fu Wei Min Gu Source Type: research
